glp 1 agonist in ckd Potential renoprotective effects of GLP1 receptor agonists. The Kidney and Cardiovascular Outcomes Among
Description
How soon can I expect to see results
[DOI] [PMC free article] [PubMed] [Google Scholar] 201.Rosenstock J, Hanefeld M, Shamanna P, Min KW, Boka G, Miossec P, Zhou T, Muehlen-Bartmer I, Ratner RE
GLP-1 medications can help with weight loss even if you dont have diabetes
J Clin Endocrinol Metab (1995) 80:9527
The cardiorenal protective effects of finerenone, a novel nonsteroidal mineralocorticoid receptor antagonist (MRA), in patients with diabetes and CKD have also been revealed in recent years [11]
Available from: _Product_Information/human/002020/WC500108241.pdf
